Evidence map›Paper›PMID 40150031›Full record

ReviewDiagnostics (Basel, Switzerland)2025

AI-Driven Advances in Low-Dose Imaging and Enhancement-A Review.

Aanuoluwapo Clement David-Olawade, David B Olawade, Laura Vanderbloemen, Oluwayomi B Rotifa, Sandra Chinaza Fidelis, Eghosasere Egbon, Akwaowo Owoidighe Akpan, Sola Adeleke, Aruni Ghose, Stergios Boussios

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aanuoluwapo Clement David-OlawadeEndoscopy Unit, Glenfield Hospital, University Hospitals of Leicester, NHS Trust, Leicester LE3 9QP, UK.ORCID 0000-0002-7052-6425
David B OlawadeDepartment of Allied and Public Health, School of Health, Sport and Bioscience, University of East London, London E16 2RD, UK.ORCID 0000-0003-0188-9836
Laura VanderbloemenDepartment of Primary Care and Public Health, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0002-6116-6018
Oluwayomi B RotifaDepartment of Radiology, Afe Babalola University MultiSystem Hospital, Ado-Ekiti 360102, Ekiti State, Nigeria.
Sandra Chinaza FidelisSchool of Nursing and Midwifery, University of Central Lancashire, Preston Campus, Preston PR1 2HE, UK.
Eghosasere EgbonDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Life Science Engineering, FH Technikum, 1200 Vienna, Austria.
Akwaowo Owoidighe AkpanDepartment of Nursing Science, Ahmadu Bello University, Zaria 810211, Kaduna, Nigeria.
Sola AdelekeGuy's Cancer Centre, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Aruni GhoseDepartment of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.ORCID 0000-0001-8332-8033
Stergios BoussiosDepartment of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.ORCID 0000-0002-2512-6131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread use of medical imaging techniques such as X-rays and computed tomography (CT) has raised significant concerns regarding ionizing radiation exposure, particularly among vulnerable populations requiring frequent imaging. Achieving a balance between high-quality diagnostic imaging and minimizing radiation exposure remains a fundamental challenge in radiology. Artificial intelligence (AI) has emerged as a transformative solution, enabling low-dose imaging protocols that enhance image quality while significantly reducing radiation doses. This review explores the role of AI-assisted low-dose imaging, particularly in CT, X-ray, and magnetic resonance imaging (MRI), highlighting advancements in deep learning models, convolutional neural networks (CNNs), and other AI-based approaches. These technologies have demonstrated substantial improvements in noise reduction, artifact removal, and real-time optimization of imaging parameters, thereby enhancing diagnostic accuracy while mitigating radiation risks. Additionally, AI has contributed to improved radiology workflow efficiency and cost reduction by minimizing the need for repeat scans. The review also discusses emerging directions in AI-driven medical imaging, including hybrid AI systems that integrate post-processing with real-time data acquisition, personalized imaging protocols tailored to patient characteristics, and the expansion of AI applications to fluoroscopy and positron emission tomography (PET). However, challenges such as model generalizability, regulatory constraints, ethical considerations, and computational requirements must be addressed to facilitate broader clinical adoption. AI-driven low-dose imaging has the potential to revolutionize radiology by enhancing patient safety, optimizing imaging quality, and improving healthcare efficiency, paving the way for a more advanced and sustainable future in medical imaging.

Indexed as

artificial intelligenceCT scansdeep learninglow-dose imagingradiation safetyradiology

Identifiers

PMID40150031
PMCPMC11941271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.